Deferred Tax Assets, Valuation Allowance in USD of RAPT Therapeutics, Inc. from Q4 2018 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
RAPT Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2018 to Q4 2024.
  • RAPT Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $134,582,000, a 26% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

RAPT Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $134,582,000 +$27,930,000 +26% 31 Dec 2024 10-K 06 Mar 2025 2024 FY
Q4 2023 $106,652,000 +$26,209,000 +33% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q4 2022 $80,443,000 +$18,955,000 +31% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q4 2021 $61,488,000 +$14,428,000 +31% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q4 2020 $47,060,000 +$12,455,000 +36% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q4 2019 $34,605,000 +$9,814,000 +40% 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q4 2018 $24,791,000 31 Dec 2018 10-K 30 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.